Stone Warren (Pres & COO) purchases 5,700 NEO shares at $8.58; 6 other insiders also bought in past 14 days amid -55.1% decline from 52-week high
Stone Warren, the President and Chief Operating Officer of NeoGenomics, purchased 5,700 shares at $8.58 on 2025-05-12, bringing his holdings to 108,280 shares. This transaction coincides with a significant cluster pattern: 6 other insiders also bought within the past 14 days. The stock is currently trading at $8.36, down 55.1% from its 52-week high of $18.61 and down 39.3% over the past 90 days. Notably, the company is unprofitable, having reported a net loss of $25,923,000 in its latest quarter against revenue of $168,035,000, though the company has achieved annual revenue growth of 11.6% year-over-year. The coordinated insider buying activity across multiple executives during a period of steep price decline warrants investor attention to understand whether this reflects internal conviction about valuation or operational recovery prospects.